Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT04181463
Phase
PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Malignant Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Isopropyl Alcohol — DRUG
    Given via nasal inhalation
  • Placebo — OTHER
    Given via nasal inhalation
  • Questionnaire Administration — OTHER
    Ancillary studies

Study Details

The goal of this research study is to understand the effect of inhalation approaches in reducing nausea in cancer patients.

Key Dates

Start date
Nov 5, 2026
Status verified
May 2026
Primary completion
Dec 30, 2028
Completion
Dec 30, 2028

Study Design

Enrollment
112 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Arm I (isopropyl alcohol)
    Patients receive isopropyl alcohol via nasal inhalation.
  • Placebo Comparator: Arm II (placebo)
    Patients receive placebo via nasal inhalation.

Primary Outcome Measure

Change in nausea [ Time Frame: Baseline up to 5 minutes post-intervention ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
M D Anderson Cancer CenterHoustonTexas77030
Michael J. Tang, MD
832-468-8895
Michael J. Tang (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
M D Anderson Cancer Center· Houston, TX

Related Studies